Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-18-021634)

Filing Details

Accession Number:
0001209191-18-021634
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-26 16:36:30
Reporting Period:
2018-03-26
Accepted Time:
2018-03-26 16:36:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1300699 Athenex Inc. ATNX Pharmaceutical Preparations (2834) 431985966
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314254 Jinn Wu C/O Athenex, Inc.
1001 Main Street, Suite 600
Buffalo NY 14203		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-26 10,000 $14.66 259,208 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Show Other Fields >>
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $4.55 2021-05-09 16,000 16,000 Direct
Common Stock Stock Option (Right to Buy) $4.55 2022-03-26 16,000 16,000 Direct
Common Stock Stock Option (Right to Buy) $4.55 2013-01-02 2023-01-02 90,000 90,000 Direct
Common Stock Stock Option (Right to Buy) $4.55 2014-02-12 2024-02-12 10,000 10,000 Direct
Common Stock Stock Option (Right to Buy) $5.50 2015-02-05 2025-02-05 54,000 54,000 Direct
Common Stock Stock Option (Right to Buy) $5.50 2025-03-20 96,000 96,000 Direct
Common Stock Stock Option (Right to Buy) $11.00 2027-06-19 28,500 28,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-05-09 16,000 16,000 Direct
2022-03-26 16,000 16,000 Direct
2023-01-02 90,000 90,000 Direct
2024-02-12 10,000 10,000 Direct
2025-02-05 54,000 54,000 Direct
2025-03-20 96,000 96,000 Direct
2027-06-19 28,500 28,500 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $14.65 to $14.66. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  2. The option vested in two equal annual installments beginning on May 9, 2012.
  3. The option vested in full on March 26, 2013.
  4. The option vested in two equal annual installments beginning on March 20, 2016.
  5. The option vests in four equal annual installments beginning on June 19, 2018.